This inventor holds 4 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Oncotherapy Science, Incorporated. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shinagawa-ku, JP (2009)
- Bunkyo-ku, JP (2011 - 2012)
- Tokyo, JP (2013)
Company Filing History:
Years Active: 2009-2013
Title: Innovations by Hidewaki Nakagawa
Introduction
Hidewaki Nakagawa is a prominent inventor based in Bunkyo-ku, Japan. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of prostate cancer. With a total of 4 patents to his name, Nakagawa's work is at the forefront of innovative medical solutions.
Latest Patents
One of Nakagawa's latest patents focuses on methods for diagnosing or treating prostate cancer. This invention provides methods for detecting and diagnosing cancer through the determination of the expression level of the STC2 gene. The STC2 gene has been discovered to effectively discriminate cancer cells from normal cells. Additionally, this patent includes methods for screening therapeutic agents useful in cancer treatment and provides double-stranded molecules targeting the STC2 gene, which are suggested to be beneficial in treating cancer. The methods and compositions outlined in this patent are particularly applicable to prostate cancer, especially castration-resistant and aggressive forms.
Another significant patent by Nakagawa involves the prostate cancer-related gene STYK1. This invention also provides methods for detecting and diagnosing cancer by determining the expression level of the STYK1 gene. Similar to the STC2 gene, STYK1 has been found to differentiate cancer cells from normal cells. This patent includes methods for screening therapeutic agents, treating cancer, and vaccinating subjects against cancer. Furthermore, it provides siRNAs targeting the STYK1 gene, which are proposed to be useful in cancer treatment.
Career Highlights
Nakagawa is currently associated with Oncotherapy Science, Incorporated, where he continues to advance his research in oncology. His work has been instrumental in developing innovative approaches to cancer diagnosis and treatment.
Collaborations
Some of Nakagawa's notable coworkers include Yusuke Nakamura and Shuichi Nakatsuru, who have collaborated with him on various research projects.
Conclusion
Hidewaki Nakagawa's contributions to cancer research through his innovative patents highlight his commitment to improving cancer diagnosis and treatment. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile